Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.

Winthrop KL, Skolnick AW, Rafiq AM, Beegle SH, Suszanski J, Koehne G, Barnett-Griness O, Bibliowicz A, Fathi R, Anderson P, Raday G, Eagle G, Ben-Yair VK, Minkowitz HS, Levitt ML, Gordon MS

Open source

DOI: 10.1093/ofid/ofac232
Published: 2022 Jul
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofac232,
  title = {Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.},
  author = {Winthrop KL and Skolnick AW and Rafiq AM and Beegle SH and Suszanski J and Koehne G and Barnett-Griness O and Bibliowicz A and Fathi R and Anderson P and Raday G and Eagle G and Ben-Yair VK and Minkowitz HS and Levitt ML and Gordon MS},
  year = {2022},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofac232},
  url = {https://doi.org/10.1093/ofid/ofac232}
}

RIS

TY  - JOUR
TI  - Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
AU  - Winthrop KL
AU  - Skolnick AW
AU  - Rafiq AM
AU  - Beegle SH
AU  - Suszanski J
AU  - Koehne G
AU  - Barnett-Griness O
AU  - Bibliowicz A
AU  - Fathi R
AU  - Anderson P
AU  - Raday G
AU  - Eagle G
AU  - Ben-Yair VK
AU  - Minkowitz HS
AU  - Levitt ML
AU  - Gordon MS
PY  - 2022
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofac232
UR  - https://doi.org/10.1093/ofid/ofac232
ER  -

APA

KL, W., AW, S., AM, R., SH, B., J, S., G, K., O, B., A, B., R, F., P, A., G, R., G, E., VK, B., HS, M., ML, L., & MS, G. (2022). Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofac232

Source records

pubmed · retrieved 2026-09-25T01:18:28.367Z